Pricing Log in Create free account

Precision BioSciences, Inc. (DTIL) vs Prelude Therapeutics Incorporated (PRLD)

Precision BioSciences, Inc. and Prelude Therapeutics Incorporated are both Biotechnology companies. Precision BioSciences, Inc. and Prelude Therapeutics Incorporated are of similar size ($283.7M and $275.7M). Precision BioSciences, Inc. has the higher net margin (0.00% vs −269.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Precision BioSciences, Inc. leads on 8 and Prelude Therapeutics Incorporated on 6.

Valuation

Metric DTIL PRLD Biotechnology median
P/E n/m n/m 10.60
P/S 6.54 15.80 9.40
P/B 5.70 2.65 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 5.22 9.03 9.02
Earnings yield (11.41%) (20.28%) (32.88%)
Free cash flow yield (17.77%) (9.41%) (23.13%)

Profitability

Metric DTIL PRLD Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% (300.56%) 0.00%
Net margin 0.00% (269.75%) 0.00%
Free cash flow margin 0.00% (148.30%) 0.00%
Return on equity (112.69%) (57.73%) (51.96%)
Return on assets (36.04%) (39.76%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DTIL PRLD Biotechnology median
Revenue growth (TTM) (11.87%) — 6.76%
EPS growth (last fiscal year) (442.31%) 23.21% 29.88%
Revenue growth, 5-year CAGR 7.13% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DTIL PRLD Biotechnology median
Debt to equity 0.43 0.00 0.00
Current ratio 10.47 4.07 4.97
Net debt to EBITDA 1.86 1.00 1.01

Dividend

Metric DTIL PRLD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DTIL PRLD Biotechnology median
Market cap 275.73m 283.70m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack